Cargando…

Use of topical bromfenac for treating ocular pain and inflammation beyond cataract surgery: a review of published studies

Topical ophthalmic nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to treat postoperative inflammation and pain following cataract surgery and for treatment and prophylaxis of pseudophakic cystoid macular edema (CME). Bromfenac is a brominated NSAID with strong in vitro anti-inflamma...

Descripción completa

Detalles Bibliográficos
Autor principal:	Schechter, Barry A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682171/ https://www.ncbi.nlm.nih.gov/pubmed/31534309 http://dx.doi.org/10.2147/OPTH.S208700

Ejemplares similares

Management of ocular inflammation and pain following cataract surgery: focus on bromfenac ophthalmic solution
por: Cho, Hyung, et al.
Publicado: (2009)

Topical Bromfenac Sodium in Femtosecond Laser-Assisted Cataract Surgery
por: Aguilar Sierra, María Camila, et al.
Publicado: (2020)

Update on twice-daily bromfenac sodium sesquihydrate to treat postoperative ocular inflammation following cataract extraction
por: Carreño, Ester, et al.
Publicado: (2012)

Topical bromfenac for prevention and treatment of cystoid macular edema following cataract surgery: a review
por: Sheppard, John D
Publicado: (2016)

Effects of Topical Prostaglandin Analog on Macular Thickness Following Cataract Surgery with Postoperative Topical Bromfenac Treatment
por: Park, Kee Sup, et al.
Publicado: (2020)

Bromfenac ophthalmic solution for the treatment of postoperative ocular pain and inflammation: safety, efficacy, and patient adherence
por: Rajpal, Rajesh K, et al.
Publicado: (2014)

Efficacy and safety of sodium bromfenac eye drops in the treatment of postoperative inflammation in cataract surgery: A protocol for systematic review and meta-analysis
por: Wang, Chunyue, et al.
Publicado: (2020)

A randomized double-masked study to compare the ocular safety, tolerability, and efficacy of bromfenac 0.075% compared with vehicle in cataract surgery subjects
por: Hosseini, Kamran, et al.
Publicado: (2016)

Effect of 0.1% Bromfenac for Preventing Macular Edema after Cataract Surgery in Patients with Diabetes
por: Song, Seok Hyeon, et al.
Publicado: (2020)

Corneal sensitivity after topical bromfenac sodium eye-drop instillation
por: Yanai, Kaori, et al.
Publicado: (2013)

Topical bromfenac as adjunctive treatment with intravitreal ranibizumab for diabetic macular edema
por: Gabr, Ahmed F., et al.
Publicado: (2023)

Protective effect of bromfenac sodium on femtosecond laser-assisted cataract surgery via modulating cyclooxygenase-2 expression
por: Lu, Lu, et al.
Publicado: (2020)

Topical bromfenac reduces multiple inflammatory cytokines in the aqueous humour of pseudophakic patients
por: Matsumura, Takehiro, et al.
Publicado: (2021)

The Effects of Two Non-Steroidal Anti-Inflammatory Drugs, Bromfenac 0.1% and Ketorolac 0.45%, on Cataract Surgery
por: Jung, Ji Won, et al.
Publicado: (2015)

Efficacy of Pretreatment with Preservative-Free Topical Bromfenac in Improving Post-Intravitreal-Injection Pain: A Prospective Pilot Study
por: Lee, Dong-Hyun, et al.
Publicado: (2022)

The Effect of Topical Bromfenac on Intraretinal and Subretinal Fluid in Neovascular Age-Related Macular Degeneration
por: Abdolrahimzadeh, Solmaz, et al.
Publicado: (2020)

Chondroitin sulfate-chitosan nanoparticles for ocular delivery of bromfenac sodium: Improved permeation, retention, and penetration
por: Abdullah, Tara Abdulrahman, et al.
Publicado: (2016)

Combination of Aflibercept and Bromfenac Therapy in Age-Related Macular Degeneration: A Pilot Study Aflibercept and Bromfenac in AMD
por: Wyględowska-Promieńska, Dorota, et al.
Publicado: (2015)

Optimization of the Ocular Surface Through Treatment of Ocular Surface Disease Before Ophthalmic Surgery: A Narrative Review
por: Schechter, Barry, et al.
Publicado: (2022)

The ocular distribution of (14)C-labeled bromfenac ophthalmic solution 0.07% in a rabbit model
por: Baklayan, George A, et al.
Publicado: (2014)

The efficacy of bromfenac ophthalmic solution 0.07% dosed once daily in achieving zero-to-trace anterior chamber cell severity following cataract surgery
por: Silverstein, Steven M, et al.
Publicado: (2014)

Bromfenac-induced neurotrophic keratitis in a corneal graft
por: Raj, Nimmy, et al.
Publicado: (2022)

Bromfenac 0.09% bioavailability in aqueous humor, prophylactic effect on cystoid macular edema, and clinical signs of ocular inflammation after phacoemulsification in a Mexican population
por: Palacio, Claudia, et al.
Publicado: (2016)

Bromfenac Ophthalmic Solution 0.07% Versus Nepafenac Ophthalmic Suspension 0.3% for Post-Cataract Surgery Inflammation: A Pilot Study of Identical Dosing Regimens with Pre-Surgical “Pulse” Dose
por: Silverstein, Steven M.
Publicado: (2019)

Safety and efficacy of twice daily administration of KPI-121 1% for ocular inflammation and pain following cataract surgery
por: Kim, Terry, et al.
Publicado: (2018)

In Vivo Pharmacokinetics of Bromfenac Ophthalmic Solution 0.075%, Bromfenac Ophthalmic Solution 0.07%, and Nepafenac/Amfenac Ophthalmic Suspension 0.3% in Rabbits
por: Sheppard, John D., et al.
Publicado: (2018)

Efficacy and safety of bromfenac 0.09% and sodium hyaluronate 0.4% combination therapy, versus placebo in patients with pterygium I–III for clinical signs on ocular inflammation
por: Chávez-Mondragón, Eduardo, et al.
Publicado: (2019)

The effect of cataract surgery on ocular dominance
por: Schwartz, Roy, et al.
Publicado: (2015)

Cataract surgery in ocular surface disease
por: Priyadarshini, K, et al.
Publicado: (2023)

An Evaluation of Staphylococci from Ocular Surface Infections Treated Empirically with Topical Besifloxacin: Antibiotic Resistance, Molecular Characteristics, and Clinical Outcomes
por: Schechter, Barry A., et al.
Publicado: (2019)

Oral versus topical carbonic anhydrase inhibitors in ocular hypertension after scleral tunnel cataract surgery
por: Al-Barrag, Abdulmoghni, et al.
Publicado: (2009)

Cataract surgery under topical anesthesia: Gender-based study of pain experience
por: Gupta, Sanjiv Kumar, et al.
Publicado: (2010)

Bromfenac 0.09% for the Treatment of Macular Edema Secondary to Noninfectious Uveitis
por: Saade, Joanna S., et al.
Publicado: (2021)

Reduced Posology of an Ophthalmic Hydrogel Containing Dexamethasone/Netilmicin to Prevent and Treat Ocular Inflammation After Cataract Surgery: Efficacy and Tolerability
por: Mencucci, Rita, et al.
Publicado: (2022)

Observation of Influence of Cataract Surgery on the Ocular Surface
por: Park, Yuli, et al.
Publicado: (2016)

Ocular surface optimization before cataract surgery
por: Venkateswaran, Nandini, et al.
Publicado: (2022)

Comparison of bromfenac 0.09% QD to nepafenac 0.1% TID after cataract surgery: pilot evaluation of visual acuity, macular volume, and retinal thickness at a single site
por: Cable, Melissa
Publicado: (2012)

Difluprednate ophthalmic emulsion 0.05% (Durezol(®)) administered two times daily for managing ocular inflammation and pain following cataract surgery
por: Smith, Stephen, et al.
Publicado: (2010)

Patient preference and pain-reported outcomes for topical versus subtenon anesthetic for cataract surgery
por: Ryan, Adam, et al.
Publicado: (2021)

Topical Anesthesia for Cataract Surgery: The Patients' Perspective
por: Apil, Aytekin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_q1eit1g2sr54bobidovlu7f45l